Cullinan Therapeutics, Inc. (CGEM) dividend history

CGEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30

$10.28+0.09 (+0.88%)

Close on Nov 13, 2026Market cap $661.57MP/E –Yield –

Dividends

No dividend per share appears in Cullinan Therapeutics's annual filings since fiscal 2019.

See a number that looks wrong?